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Abstract
The DNA/RNA processing protein TDP-43 undergoes both functional and pathogennic 
aggregation. Functional TDP-43 aggregates form reversible, transient species such as nuclear 
bodies, stress granules, and myo-granules. Pathogenic, irreversible TDP-43 aggregates form in 
amyotrophic lateral sclerosis (ALS) and other neurodegenerative conditions. Here we find the 
features of TDP-43 fibrils that confer both reversibility and irreversibility by determining 
structures of two segments reported to be the pathogenic cores of human TDP-43 aggregation: 
SegA (residues 311–360), which forms three polymorphs, all with dagger-shaped folds; and SegB 
A315E (residues 286–331 containing the ALS hereditary mutation A315E), which forms R-
shaped folds. Energetic analysis suggests that the dagger-shaped polymorphs represent irreversible 
fibril structures, whereas the SegB polymorph may participate in both reversible and irreversible 
fibrils. Our structures reveal the polymorphic nature of TDP-43 and suggest how the A315E 
mutation converts the R-shaped polymorph to an irreversible form which enhances pathology.
INTRODUCTION
Amyloid-forming proteins seem to violate the central tenant of protein science—that amino 
acid sequence determines structure and function1. In contrast to globular and membrane 
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proteins each of which folds into a single functional structure, a given amyloid-forming 
sequence can fold into several distinctly different polymorphic structures2,3.
Irreversible, hyperphosphorylated, amyloid-like aggregates of C-terminal segments of 
TDP-43 are the primary pathology of amyotrophic lateral sclerosis (ALS) and 
frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP)4–6. These 
aggregates have also been found in Alzheimer’s, Parkinson’s, CTE, Huntington’s disease, 
Limbic-predominant age-related TDP-43 encephalopathy (LATE) and inclusion body 
myopathies (IBMs), among others7–11. Because TDP-43 functions in several essential steps 
of RNA metabolism12,13, it is widely considered that TDP-43 aggregation is toxic through a 
loss-of-function mechanism14–16. Structural studies of amyloid fibrils of β-amyloid17,18, 
tau19,20, α-synuclein2, and β2-microglobulin21 have revealed polymorphs and insights into 
pathogenesis. Here, we use cryo-EM to determine the overall folds of TDP-43 amyloid 
cores, expanding structural information about both reversible and irreversible aggregation 
beyond the local interactions previously revealed by crystallography22,23.
RESULTS
Generating TDP-43 fibrils
We screened for TDP-43 fibrils by incubating various SUMO-tagged TDP-43 segments in 
the test tube after the cleavage of SUMO tag (Supplementary Figure 1a and Supplementary 
Table 1). We first aimed to produce fibrils formed by full-length TDP-43, a pathogenic C-
terminal fragment (CTF, 208–414) – truncation product that is enriched in disease brain24, or 
by the Low Complexity Domain (LCD, 274–414) which is considered to be necessary for 
TDP-43 aggregation22,25,26. However, despite our efforts at optimization, we could observe 
only highly clumped fibril-like structures and disordered aggregates that are not suitable for 
cryo-EM structure determination (Supplementary Figure 1b top panel). We suspect that this 
may be due to the ability of longer constructs of TDP-43 to participate in multi-valent 
interactions, possibly through LARKS22,27 or other adhesive segments outside the LCD23. 
These multi-valent interactions have been shown to assemble networks of protein chains and 
could conceivably explain why longer segments of TDP-43 form amorphous aggregates or 
fibril clumps. This observation is in line with TDP-43’s role in phase separation and stress 
granule formation, which requires the presence of multi-valent interactions27.
To overcome the hurdle of the disordered assembly of longer segments of TDP-43, we 
implemented a “divide and conquer” approach whereby we selected known aggregation 
cores for structure determination. We chose SegA (residues 311–360) and SegB (residues 
286–331), guided by the following evidence. SegA was previously identified as an 
aggregation core of TDP-43 due to the observation that its deletion decreases TDP-43 
aggregation in vitro and in cells, whereas addition of SegA to the aggregation-resistant C. 
elegans TDP-43 homolog induces aggregation28. Fibrils of SegB are toxic to primary 
neurons, and an ALS hereditary mutation A315T together with phosphorylation of the 
threonine, which is speculated to occur in hyper-phosphorylated aggregates of TDP-43 in 
disease, increases SegB’s cytotoxicity29. With this in mind, we selected SegB A315E – 
another hereditary mutation with similar effects as A315T29–32 and a mimic of A315T with 
phosphorylation – in order to visualize the structure of a second possible TDP-43 
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aggregation core and to gain insight into the molecular mechanism of mutation-enhanced 
TDP-43 pathology. The importance of SegA and SegB in full-length TDP-43 aggregation is 
also supported by other studies which found that amyloid fibrils containing either a core 
region (residues 314–353) of SegA or region (residues 274–313) similar to SegB can 
template aggregation of full-length TDP-43 in SH-SY5Y human neuronal cells33. Likewise, 
in the same cell line, deletion of these two regions (residues 314–353 or 274–313) from full-
length TDP-43 inhibits aggregation.
Architecture of SegA and SegB fibrils
As we expected, fibrils formed by SegA and SegB A315E were much more homogenous 
and less bundled than longer segments of TDP-43, including SegAB (286–360) that contains 
both aggregation cores SegA and SegB (Supplementary Figure 1b). This observation 
supports the idea that eliminating competing multi-valent interactions helps to produce 
homogenous fibrils of isolated amyloid cores. Using these homogenous preparations, we 
determined three polymorphic fibril structures of SegA (termed SegA-sym, SegA-asym, and 
SegA-slow) and one of SegB A315E (Figure 1, Supplementary Figure 2–4 and Table 1; see 
Online methods for technical details).
All four fibrils are formed from gradually twisting β-sheets that run the entire length of the 
fibrils (Figure 1b–e). A thin slab or “layer” perpendicular to each fibril axis (Figure 1, 
middle) shows that individual SegA and SegB chains are each confined within an essentially 
two-dimensional layer, in contrast to globular and membrane proteins whose folds occupy 
three-dimensions. Identical layers stack on one another creating β-sheets that are parallel 
and in-register. Each layer contains two or more protein chains, giving rise to a 
corresponding number of protofilaments in the fibril.
The dagger-shaped fold in SegA polymorphs
SegA polymorphs all share a dagger-shaped fold comprised of residues 312–346 with the 
hydrophobic residues from Phe313 to Ala341 forming tight hydrophobic interactions, and a 
sharp 160° kink at Gln327 forming the dagger tip (Figure 2a–d and Supplementary Figure 5, 
detailed comparison in following two paragraphs and Supplementary Figures 5,6). The three 
SegA polymorphs mainly differ in the number of protofilaments and symmetry. SegA-sym 
fibrils contain two protofilaments related by a pseudo-21 axis, whereas SegA-asym contains 
two protofilaments with somewhat different conformations. SegA-slow fibrils contain four 
protofilaments; two protofilaments are related by a central 2-fold axis and contain 50 
ordered residues. These are flanked by two other protofilaments containing only 10 ordered 
residues.
The core region of the dagger-shaped fold (residue 320–334) is almost identical in all four 
dagger-shaped folds of three SegA polymorphs (Figure 2a and Supplementary Figure 5). 
Besides that, detailed single chain superposition shows that SegA-sym and the long chain of 
SegA-asym have nearly identical dagger-shaped folds, with the “stem” of the long chain 
SegA-asym (Ala341 to Ser347) bent approximately 40° (Figure 2c). This bending of the 
long chain SegA-asym stem forces a 40° bend in the “blade” of the SegA-asym short chain 
relative to the reference SegA-sym fold, corresponding to the shift in registration of the stem 
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hydrophobic interdigitation (Supplementary Figure 5, bottom left). In addition, the “stem” of 
SegA-slow (Ala341 to Ser347) is bent approximately 50° compared to SegA-sym 
(Supplementary Figure 5, bottom right), causing a significant conformational change at 
Met336. Further, the interaction of the termini in SegA-slow causes a conformational change 
at Phe313, Phe316 and Met339; and M311 is now visualized and participating in the 
hydrophobic core (Supplementary Figure 5, bottom right).
The protofilament interface in SegA-sym and SegA-asym are similar (Supplementary Figure 
6a,b) with slight differences in the region that has a 40° bend (Supplementary Figure 6b, 
right). We name this the continuous interface since it is formed by two continuous chains, as 
opposed to the broken interface in SegA-slow formed by the interaction of the termini 
(Supplementary Figure 5). The continuous interface has a hydrophobic core formed by 
Met336 and Leu340 from both monomers and a hydrogen bond network towards the edges 
(Figure 2d & Supplementary Figure 6a). The broken interface is formed largely by the tight 
packing of Met359 and the hydrogen bonding network of the peripheral asparagine residues 
(Supplementary Figure 6a). We observed only part of the continuous interface in SegA-slow, 
probably due to the conformational change of Met336 (Supplementary Figure 6c,d, see 
detailed model building in Online methods).
We note that SegA-sym and SegA-asym structures are compatible with full-length TDP-43 
due to their free N-and C-termini, whereas the SegA-slow structure is an artifact of the 
truncation since the N- and C-termini are sequestered in the center of the fibrils (Figure 1d 
and Supplementary Figure 6a). Therefore, in the following analysis, we mostly focus on 
SegA-sym and SegA-asym. However, we note that SegA-slow provides valuable 
information, as discussed below. First, the SegA-slow structure contains the dagger-shaped 
fold, demonstrating its conservation in the three different polymorphs we observe for SegA 
(Supplementary Figure 5). We note that the incompatibility of SegA-slow to full-length 
TDP-43 comes from the tail region (residues 347–360) which is external to the dagger-
shaped fold (Supplementary Figure 7a, upper panel). Thus, taken alone, the dagger-shaped 
fold in SegA-slow (residues 312–346) is still compatible with full-length TDP-43, as in 
SegA-sym and SegA-asym. Second, the tail region hairpin structure (residues 342–360) in 
SegA-slow is also compatible with full-length TDP-43 when separated from the dagger-
shaped fold, with free N- and C- terminals (Supplementary Figure 7a bottom panel). This 
hairpin structure is formed by tightly packed hydrophilic zippers stabilized with extensive 
hydrogen bonds (Supplementary Figure 7b). Based on the analysis above, we speculate that 
this hairpin structure may also be involved in TDP-43 aggregation as another segmental 
polymorph. Further study is needed to test this hypothesis as well as identify whether this 
hairpin contributes to reversible or irreversible aggregation of TDP-43. Third, our SegA-
slow structure provides, to our knowledge, the first atomic evidence in support of secondary 
seeding of amyloid fibrils. Secondary seeding is considered to occur when the side of pre-
formed fibrils serves as a template for new monomers to nucleate into an amyloid fibril. This 
is in contrast to primary seeding where molecules add to the top or bottom of pre-formed 
fibrils. In this case, the extra density near Q331 and M323 of the long chain of SegA-slow 
indicates that secondary seeding can occur on these regions (Figure 1d). Because the long 
chain of SegA-slow contains all 50 residues in SegA, the extra density must come from 
other SegA molecules, therefore supporting a secondary seeding mechanism. In comparison, 
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similar extra density has been observed in other amyloid fibril structures, such as the tau 
Paired Helical Filament (PHF)19; but in these structures the ordered fibril core does not 
contain all residues of the molecule. Therefore it is not certain whether these densities come 
from binding of a different molecule or from sequences outside of the fibril core of the same 
molecule.
The R-shaped fold in the SegB fibril
SegB A315E forms fibrils of a single morphology, in contrast to polymorphic SegA. These 
fibrils are characterized by an R-shaped fold spanning residues 288–319 (Figure 2e,f). 
Overall, the R-shaped fold is more highly kinked than the dagger-shaped fold (Figure 1b–e), 
probably due to the abundance of glycine residues. Each fibril is wound from four 
protofilaments (Figure 2e). The two inner protofilaments are related through a tight, 
pseudo-21 symmetric interface (Figure 2e,g). These protofilaments are flanked by two outer 
protofilaments through an asymmetric interface (Figure 2e,g). The symmetric interfaces are 
formed by small side chain residues (Gly298 and Gly300) in the middle (reminiscent of the 
homodimer interface in the tau PHF structure from Alzheimer’s disease19) and hydrogen 
bonds among Gln303, Gly295, Ala297 and Gln301 (Figure 2g, left and Supplementary 
Figure 8a ). The asymmetric interfaces are formed by hydrophobic interaction of Ile318, 
Phe316 with Phe289, the insertion of Leu299 into the pocket formed by the main chain of 
Asn306-Gly309, hydrophobic interaction of Phe289 (from another inner chain) and the main 
chain Asn303-Gly304, and hydrogen bonds among Met311, Asn312, and Gly290-Ser292 
(Figure 2g, right and Supplementary Figure 8a).
The overall R-shaped folds of the inner and outer chain of the SegB A315E fibril are largely 
similar with some salient differences (Figure 2f), which recall the positional polymorphism 
observed in a different, shorter TDP-43 segment23. The head region of the inner chain is 
formed by the hydrophobic interaction of Leu299, Met307, Met311 and Phe313, as well as 
by Asn302 and Ser305 hydrogen bonding; whereas in the outer chain, Leu299 is flipped 
outside the head to mediate the heterodimer interaction between the inner and outer chain 
(Figure 2f). Consequently, the head region of the outer chain is formed by the hydrophobic 
interaction of Met307, Met311 and Phe313, together with hydrogen bonds formed by 
Asn301, Asn302 and Ser305 (Figure 2f, Supplementary Figure 8b). The neck region of both 
chains is formed by hydrophobic interaction between Ala297 and Phe313, the Arg293-
Glu315 salt-bridge. The 70° bend of the Phe316-Asn319 leg of the outer chain relative to the 
inner chain is probably caused by the heterodimer interface formed by the legs of the inner 
and outer chain that restricts the conformation of the inner chain.
In all four R-folds we observe a salt-bridge between Arg293 and Glu315 enabled by the 
pathogenic A315E mutation. The Arg293-Glu315 salt-bridge is not formed by the residues 
from the same layer along the fibril axis. Rather, each Arg293 interacts with the Glu315 
from one or two layers above (Figure 2h), which may affect the kinetics of fibril growth and 
nucleation. This salt-bridge suggests a mechanistic explanation for the inclination of A315E 
toward TDP-43 pathology (see Discussion). Model building suggests that wild-type SegB 
can form the same R-shaped fold as A315E, with Ala315 participating in a hydrophobic 
interaction with Ala297 and Phe313. This hypothesis is supported by the similar stability 
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and morphology of wild-type SegB fibrils in our themostability assays (Supplementary 
Figure 1c) compared to SegB A315E fibrils and is also supported by the cross-seeding 
ability of SegB and SegB A315E (Supplementary Figure 1e).
It is noteworthy that although TDP-43 can form either the dagger-shaped polymorph of 
SegA or the R-shaped polymorph of SegB, it is unlikely that a given molecule of TDP-43 
can form both simultaneously. This exclusivity is indicated by a superposition of the two 
folds in the overlapping segment Asn312-Asn319 (Supplementary Figure 8c). The 
superposition reveals that steric overlap between the main chains of SegA and SegB would 
occur if both folds were formed by a single TDP-43 molecule containing both SegA and 
SegB sequences.
Stability of SegA and SegB fibrils
The extensive hydrophobic interactions and hydrogen bonds observed in both the dagger- 
and R-shaped folds suggest that both SegA and SegB A315E fibrils are irreversible. To 
examine this hypothesis, we calculated modified atomic solvation energies (see Online 
methods) to quantify the stabilities of the fibrils. The calculated stabilities of both the 
dagger- and R-shaped fold fibrils (represented by energy per layer and per residue) are 
comparable to other pathogenic amyloid fibrils, such as the Alzheimer’s and Pick’s disease 
fibrils (Figure 3 and Table 2). In contrast, the stability of FUS fibrils, thought to be 
reversible34, is distinctly lower.
We performed thermostability assays to validate our energetic calculations. When heated to 
75 °C for 30 minutes, fibrils formed by SegA, SegB, and SegB A315E were all stable, 
whereas fibrils formed by mCherry-FUS-LCD (composed of residues 1–214 – identical to 
the sequence determined in the FUS ssNMR structure except with a His-tag replacing 
mCherry34) disappeared upon heating at 60 °C (Supplementary Figure 1c). These results are 
consistent with our energetic calculations and support the idea that the dagger- and R-shaped 
fold fibrils are irreversible.
SegA and SegB folds can be adopted by longer TDP-43 segments
Several lines of evidence suggest that the dagger and R-shaped folds can be adopted by 
longer TDP-43 segments such as the pathogenic TDP-CTF fragment. (1) Structural 
conservation: the core region (residue 320–334) of the dagger-shaped fold is structurally 
conserved in all four dagger-shaped folds despite differences in local environment (Figure 
2a). This high degree of structural conservation suggests this core region of dagger-shaped 
fold is thermodynamically stable, kinetically accessible and is likely to be present in other 
polymorphs (perhaps including disease relevant TDP-43 aggregates). (2) Model building: 
the outward facing disposition of the termini in these folds allows longer TDP-43 structures 
to be modeled from these cores without steric interference. (3) Cross seeding: fibrils formed 
by TDP-CTF can seed SegA and SegB A315E monomer (Supplementary Figure 1f), and 
SegA and SegB A315E fibrils can seed TDP-LCD monomer (Figure 4b) (due to its rapid 
aggregation, TDP-CTF monomer could not be used to measure seeding and we instead used 
TDP-LCD monomer as the LCD is required for TDP-43 aggregation22,25,26). (4) 
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Mutagenesis experiments with TDP-CTF reported previously22 and here, as described 
below.
We found that five individual point mutations to tryptophan delay aggregation of TDP-CTF; 
these sterically conflict with the tightly packed dagger-shaped (A324W, L330W, Q331W, 
M337W) and R-shaped folds (Q303W) and delay aggregation of TDP-CTF22. In SegA-sym, 
three of these mutation sites (Ala324, Leu330 and Met337) point toward the center of the 
dagger-shaped fold and the other one (Gln331) points toward the “continuous dimer 
interface” (Figure 2b & Supplementary Figure 9a,b), and in SegB A315E, Gln303 of the 
inner chain is buried within the inter-chain interface (Supplementary Figure 9a,b and 
Supplementary Figure 10). All four sites are buried in a tightly packed interface that cannot 
tolerate a tryptophan replacement. Similarly, the mutations A324E and M337E that are 
disruptive to the dagger-shaped fold are found to inhibit aggregation of full-length TDP-43 
in cells28. As negative controls, we found that A326W and G304W – located in a solvent 
exposed environment of the dagger-shaped fold and a loose cavity of the R-shaped fold, 
respectively – can tolerate the bulky tryptophan and did not delay aggregation of TDP-CTF 
(Supplementary Figure 1d, Supplementary Figure 9a&b)22. Furthermore, a key stabilizing 
feature of SegB A315E, the Arg293-Glu315 salt bridge, is similarly important for TDP-CTF 
aggregation. We designed two double mutants, R293E A315E and R293E A315R, based on 
our structure of SegB A315E. R293E A315E would disrupt the R-shaped fold by 
electrostatic repulsion whereas R293E A315R would favor the R-shaped fold by restoring 
the salt-bridge. In accordance with our model, R293E A315E reduces TDP-CTF aggregation 
whereas R293E A315R enhances TDP-CTF aggregation (Supplementary Figure 1d).
These results suggest that both the dagger- and the R-shaped folds are accessible to TDP-
CTF molecules, so that disrupting either one blocks one pathway to fibril formation and 
hence delays aggregation of TDP-CTF. The observation that none of these mutations 
targeting the dagger- or R-shaped fold fully eliminates aggregation supports our hypothesis 
that TDP-CTF can form fibrils using one of multiple aggregation cores, including the 
dagger- or R-shaped fold, or possibly others not discovered here. In short, conservation of 
the dagger fold, modeling, seeding experiments, and mutational analysis all suggest that 
TDP-CTF can form the folds we observe.
Relevance of the dagger- and R- folds for human disease
We investigated whether the dagger- and R-shaped folds are relevant to TDP-43 fibrils in 
human disease, motivated by the irreversibility of fibrils formed by these folds and the likely 
accessibility to both folds of TDP-CTF. The scarcity of TDP-43 fibrils in autopsied brains of 
ALS and FTLD patients daunts structure determination of patient-derived TDP-43 fibrils, so 
we used seeding experiments to examine the possibility that our structures represent folds 
adopted by TDP-43 in disease.
We seeded both SegA and SegB A315E monomer with sarkosyl-insoluble material from 
brain extracts of two patients with FTLD-TDP, which was previously reported to induce 
FTLD-TDP pathology in a mouse model35. The sarkosyl-insoluble material was able to seed 
SegA monomer (Supplementary Figure 1g), indicating that in these FTLD-TDP brain 
extracts, TDP-43 contains a well-folded SegA region that can serve as a template for seeded 
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aggregation, thereby providing plausibility for the existence of the dagger-shaped fold in 
these extracts. In contrast we found that the same brain extracts cannot seed SegB A315E 
monomer (Supplementary Figure 1g), suggesting that the R-shaped fold may not exist in 
these extracts. This lack of seeding may mean that the R-shaped fold is specific for patients 
bearing the TDP-43 A315E mutation. Alternatively, the R-shaped fold may not exist in this 
particular FTLD patient but may exist in other TDP-43 diseases or disease subtypes such as 
ALS, especially given that the A315E mutation was discovered in the context of ALS36.
We thus propose a one-to-one correspondence between polymorph and disease subtype. 
More specifically, we speculate that the difference between SegA-sym and SegA-asym are 
so subtle that they may be associated with the same diseases whereas the differences 
between the dagger- and R-shaped fold are substantial enough to perhaps be associated with 
different diseases. This hypothesis is supported by : (1) insoluble TDP-43 extracts from 
different sub-types of FTLD have distinct morphologies and biochemical properties37, and 
(2) fibrils of two peptides whose sequences closely match the dagger-shaped fold and the R-
shaped fold (Supplementary Figure 9c) seed cell-expressed TDP-43 into distinct 
aggregates33.
DISCUSSION
Our finding of polymorphism of TDP-43 fibrils adds TDP-43 to the cohort of other 
polymorph-forming amyloid proteins2,18–20, and raises the question of why polymorphism is 
common in amyloid fibrils but not in globular proteins. We suggest that the polymorphism 
observed in irreversible amyloid fibrils arises from a lack of evolutionary pressure to fold 
into a particular structure that performs an adaptive function. In contrast, each globular 
protein and functional aggregate has evolved to fold into a single structure with lower free 
energy than any other structure that its sequence can form. That is, pathogenic amyloid 
fibrils lack survival advantage and so can adopt multiple conformations that represent 
different local energy minima in the protein folding landscape. However, a particular 
polymorph may give rise to a particular disease38, perhaps nucleated by a mutation such as 
TDP-43 A315E or a particular cellular environment as suggested for alpha-synuclein39. 
Polymorph-specific diseases are consistent with results on tau where multiple patients with 
the same tauopathy all are found to have the same fibril polymorphs and patients with 
different tauopathies have different fibril polymorphs19,20,40.
Our structure of SegB A315E, to our knowledge the first reported cryo-EM fibril structure 
containing a hereditary mutation, offers a molecular mechanism in terms of seeding for cell-
to-cell spreading of pathology through the brain40. As explained above, our SegB A315E 
structure indicates that A315E facilitates TDP-43 aggregation through electrostatic attraction 
with Arg293, and suggests A315T (if the threonine is phosphorylated as speculated) can 
function in a similar way. As summarized in Figure 4a, wild-type TDP-43 monomer can 
form either the dagger-shaped or R-shaped fold (or possibly other folds), and both folds can 
act as seeds to recruit additional monomers into the fibril. In A315E, the inter-layer 
interaction motif of Arg293-Glu315 provides free positive and negative charges on both ends 
of any R-shaped fibril that consists of 2 layers or more (Figure 2h), and these free charges 
can attract additional monomers through long-range electrostatic interactions. Thus the 
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seeding potency of the R-shaped fold with the A315E mutation may exceed that of other 
folds. Our seeding experiments support this model by showing that SegB A315E fibrils are 
more effective in seeding TDP-LCD A315E monomer than SegA fibrils as discussed below 
(Figure 4b).
The observation that both SegA and SegB A315E fibrils can seed LCD monomer (Figure 4b, 
far-left and middle-left panel) indicates that the LCD can adopt both the dagger- and R-
shaped folds when seeded and also suggests roughly equal seeding ability of both dagger- 
and R-shaped folds. In addition, we found SegA fibrils barely seed LCD A315E monomer 
(Figure 4b, middle-right panel) whereas SegB A315E fibrils can seed LCD A315E monomer 
(Figure 4b, far-right panel). We doubt these results arise from the incompatibility of the 
dagger-shaped fold with the A315E mutation because Ala315 in the dagger-shaped fold 
faces the solvent so that the A315E mutation should be allowed (Supplementary Figure 9d). 
Instead, the results shown in Figure 4b middle-right and far-right panels indicate that the 
seeding ability of the R-shaped fold is much higher than the dagger-shaped fold when 
seeding A315E monomer. In this case, the observation that SegA fibrils barely seed LCD 
A315E monomer can be explained by the enhanced primary nucleation and self-seeding of 
LCD A315E monomer via the Arg293-Glu315 salt-bridge, so that the self-seeded 
aggregation overwhelms the seeding of SegA fibrils. Taken together, the seeding 
experiments shown in Figure 4b support our hypothesis that the salt-bridge introduced by 
A315E mutation accelerates the aggregation of the R-shaped fibrils.
Addition mechanisms proposed for hereditary mutations to impart pathology include the 
shift of TDP-43 from a reversible to an irreversible assembly41,42. Although we have shown 
that both dagger- and R-shaped folds form irreversible fibrils, and others have shown that the 
C-terminal domain can form helical assemblies in liquid droplets42, under certain conditions 
the dagger- and R-shaped folds may also participate in reversible aggregation. Energetic 
analysis suggests this may be possible for the R-shaped fold. The outer two chains in the 
SegB A315E structure differs noticeably from the inner two chains, having a lower 
stabilization energy (0.79 kcal/mol per residue), close to the stabilization energy of the FUS 
structure (0.66 kcal/mol per residue), which undergoes reversible aggregation, versus the 
inner chain (0.94 kcal/mol per residue, Table 2). We speculate that the structural and 
energetic differences between the outer and inner chains are perhaps due to the flexibility of 
the R-shaped fold owing to its high glycine content and relatively small hydrophobic core. In 
humans lacking the A315E mutation, the absence of the Arg293-Glu315 salt bridge would 
eliminate the electrostatic attraction that helps to fix the R-shape, perhaps allowing the 
molecule to partially unfold to a more open U-shape. This conformational change may 
further compromise the stability of the R-shaped fold by promoting the disassembly of the 
four-protofilament bundle given the observation that the symmetric interface of the R-shaped 
fold is relatively weak (Figure 2g) and formation of the asymmetric interface requires the 
closed conformation of the inner R-shaped folds. Therefore, the transition from reversible to 
irreversible assemblies may occur through a U-R switch where a more open and less 
bundled U-shape fold converts to a more compact and more bundled R-shape. This U-R 
switch is possible for both wild-type and A315E, although perhaps the wild-type sequence 
would have a higher transition state energy owing to the loss of the Arg293-Glu315 
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interaction. That is, we speculate that the A315E mutation could impose a switch from a 
reversible to an irreversible assembly.
We note that our energy analysis relies on the structure of one reversible fibril and that we 
have no experimental evidence regarding the role of the R-shaped polymorph in reversible 
TDP-43 aggregation; therefore, further research identifying structures of reversible fibrils 
and interrogating the role of the R-shape in TDP-43 reversible aggregation is needed.
Our hypotheses proposed in the preceding four paragraphs are only two of numerous 
possibilities for mutation-enhanced toxicity in TDP-43 proteinopathies and may not apply to 
hereditary mutations other than A315E. We observe that many hereditary mutations would 
have a neutral, or even deleterious, effect on the dagger- and R-shaped folds (Supplementary 
Figure 9d). This is consistent with the idea that there are other observed mechanisms for 
mutation-enhanced pathology, such as toxic gain-of-function RNA splicing activity43. In 
addition, these mutations may influence the formation of other amyloid cores not discovered 
here.
Our four near-atomic resolution structures of TDP-43 amyloid fibrils establish that: (1) 
TDP-43 is capable of forming multiple fibrillar structural polymorphs; (2) That two 
sequence segments of TDP-43 can form distinct stable amyloid cores, one with dagger-
shaped folds and the other with R-shaped folds; (3) The R293-E315 salt-bridge in R-shaped 
fold provides a plausible explanation of enhanced TDP-43 pathology by the ALS related 
hereditary mutation A315E (and possibly A315Tp); and (4) Energetic analysis highlights the 
structural features of amyloid fibrils that may lead to both reversible and irreversible 
aggregation.
ONLINE METHODS
Construct design
Construct design of TDP-43 segments follows the same strategy reported previously22. In 
addition to TDP-LCD (274–414) reported in our previous study22, constructs used in this 
study include TDP-43 full length (1–414), SegA (311–360), SegB (286–331, wild type or 
with A315E mutation) and SegAB (286–360). All TDP-43 fragments were conjugated by 
inserting the cDNA into a pET28a vector that contains an amino terminus conjugation of 
SUMO protein. The SUMO protein was used to increase solubility and prevent aggregation 
during expression and purification. The (His)6-tag on the amino terminus of the SUMO 
protein was used for Ni-column purification. The expression sequence of each TDP-43 
fragments is shown in Supplementary Table 1.
Protein purification and SUMO-tag cleavage
Protein purification follows the same protocol reported previously22. Briefly, all SUMO-
tagged proteins were expressed in Escherichia coli BL21 (DE3) strain. LB media with 50 
μg/ml kanamycin was used for cell culture. After bacterial cells were cultured at 37 °C to an 
OD600 of 0.6–0.8, 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) was added for 
protein expression and the cells were further cultured at 25 °C for 3 h. Cells were harvested 
and resuspended in 20 mM Tris-HCl, pH 8.0, 500 mM NaCl, 20 mM imidazole, 10% (v/v) 
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glycerol, supplemented with 1% (v/v) Halt Protease Inhibitor single-use cocktail (Thermo 
Scientific), and were sonicated (3s on/3s of cycle, 10 min) and centrifuged (24,000 g for 20 
min) to get cell lysate. The cell lysate was mixed with homemade NucA nuclease (5000 U 
per liter of cell culture) and filtered before loading onto a HisTrap HP column (GE 
healthcare) for purification. The HisTrap column was pre-equilibrated with 20 mM Tris-
HCl, pH 8.0, 500 mM NaCl and 20 mM imidazole, and sample was washed with 20 mM 
Tris-HCl, pH 8.0, 500 mM NaCl and 200 mM imidazole and eluted with 20 mM Tris-HCl, 
pH 8.0, 500 mM NaCl and 500 mM imidazole. Eluted protein was concentrated using 
Amicon Ultra-15 centrifugal filters (Millipore) and stored at −80 °C for future use.
In order to form fibrils of the TDP-43 fragments, the SUMO-tag of each fragment was 
removed before aggregation. SUMO-tagged protein was mixed with 100:1 (weight basis) 
homemade ULP1 protease, and incubated for 1 hour. When analyzed by SDS-PAGE, 
samples mixed with ULP1 at 0 hour show bands of intact SUMO-tagged protein; after 1 
hour of cleavage, bands of free SUMO and TDP-43 fragments were shown on the gel, as 
exampled by SegA and SegB A315E cleavage shown in Supplementary Figure 1a.
Fibril preparation and optimization
SUMO-tag removed proteins were used for fibril preparation. For all TDP-43 fragments, the 
starting fibril preparation conditions are the same. Protein was diluted to 50 μM 
concentration with 20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 10 μM DTT and filtered using 
0.1 μm Ultrafree-MC-VV centrifugal filters (Millipore), and incubated at 37 °C with shaking 
for 3 days. The morphology of each sample was checked by negative stain TEM.
In order to achieve the necessary fibril concentration and distribution for cryo-EM structure 
determination, the fibril growth condition was optimized for each sample. The optimization 
includes determining the appropriate concentration of proteins (final values ranging from 3 
μM to 100 μM monomer concentration), incubating the solution without shaking, incubation 
temperature (4 °C or 25 °C or 37 °C), incubation time (overnight to more than 2 weeks), 
buffer (Tris or phosphate), salt concentration (50 mM to 500 mM NaCl) and seeding with 
pre-formed fibrils. After optimization of all TDP-43 fragments, SegA and SegB A315E were 
found to have the best fibril morphology, distribution, and concentration and were therefore 
selected for cryo-EM structure determination. The optimized fibril morphology of each 
fragment is shown in Supplementary Figure 1b.
The optimized fibril growth condition for SegA was 50 μM protein concentration, incubation 
in 20 mM Tris-HCl, pH 7.4, 500 mM NaCl, 10 μM DTT at 37 °C with 3 days of shaking. 
Two percent (molar ratio, monomer equivalent) pre-formed SegA fibrils were added as 
seeds. After shaking, SegA fibrils were collected by centrifugation at 9,000 g for 5 min and 
washed twice and resuspended to the starting volume with the identical buffer as above, 
except using 150 mM NaCl instead of 500 mM. Fibrils in resuspension buffer were further 
incubated without shaking for 3 days at room temperature. Before cryo-EM sample 
preparation, SegA fibrils were again collected by centrifugation, and re-suspended with 150 
mM NaCl buffer at 5% volume of previous incubation (20 × concentrating), and the 
concentrated solution was heated to 75 °C for 30 min with a PCR machine. The final heating 
step was necessary to de-clump SegA fibrils and optimize fibril distribution.
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The optimized fibril growth condition for SegB A315E was 50 μM initial protein 
concentration, and incubation in 20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 10 μM DTT, at 37 
°C without shaking. Two percent (molar ratio, monomer equivalent) pre-formed SegB 
A315E fibrils were added as seeds. After incubation, SegB A315E fibrils were collected by 
centrifugation at 9,000 g for 5 min and washed twice by the same incubation buffer at 5% 
volume of previous incubation (20 × concentrating), and the concentrated solution was used 
for cryo-EM sample preparation.
Negative stain transmission electron microscopy (TEM)
Negative stain TEM samples were prepared by applying 5 μl of fibril solution to glow-
discharged 400 mesh carbon-coated formvar support films mounted on copper grids (Ted 
Pella, Inc.) and incubating on the grid for 2 min. The samples were then blotted off and the 
grids were stained with 3 μl of 2% uranyl acetate for 1 min. The grids were washed with an 
additional 3 μl of 2% uranyl acetate and allowed to dry for 1 min. Each grid was imaged 
using a T12 (FEI) electron microscope.
Cryo-EM data collection and processing
2 μl of fibril solution was applied to a glow-discharged Quantifoil 1.2/1.3 electron 
microscope grid and plunge-frozen into liquid ethane using a Vitrobot Mark IV (FEI). Data 
were collected on a Titan Krios (FEI) microscope equipped with a Gatan Quantum LS/K2 
Summit direct electron detection camera (operated with 300 kV acceleration voltage and slit 
width of 20 eV). Super-resolution movies were collected on a Gatan K2 Summit direct 
electron detector with a nominal physical pixel size of 1.07 Å /pixel (0.535 Å/pixel in super-
resolution movie frames) with a dose per frame of ~1.1 e−/Å2. A total of 40 frames with a 
frame rate of 5 Hz were taken for each movie resulting in a final dose of ~44 e−/Å2 per 
image. Automated data collection was driven by the Leginon automation software 
package44.
Micrographs containing crystalline ice were used to estimate the anisotropic magnification 
distortion using mag_distortion_estimate45. CTF estimation was performed using CTFFIND 
4.1.8 on movie stacks with a grouping of 3 frames and correction for anisotropic 
magnification distortion46. Unblur47 was used to correct beam-induced motion with dose 
weighting and anisotropic magnification correction, resulting in a physical pixel size of 1.06 
Å/pixel and 1.064 Å/pixel for the SegB and SegA data sets, respectively.
All particle picking was performed manually with SegB A315E data set fibrils picked as a 
group and SegA data set fibrils were picked separately in groups of slow twister and fast 
twisters using EMAN2 e2helixboxer.py48 (we could not discriminate between SegA-sym 
and SegA-asym by eye due to their similar crossover distances and morphology; therefore, 
SegA-sym and SegA-asym particles were later separated by 2D classification and 3D 
classification). Particles were extracted in RELION using the 90% overlap scheme into 288 
pixel boxes for SegA and 320 pixel boxes for SegB A315E. Classification, helical 
reconstruction, and 3D refinement were used in RELION as described49–51. In general, we 
performed 2D Classifications with higher tau_fudge (ranging from values of 4 to 12) to 
identify, and select for future 3D classification, particles contributing to 2D classes showing 
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β-strand separation along the helical axis. We performed 3D classification with the 
estimated helical parameters from each structure and an elongated Gaussian blob as an 
initial model to generate starting reconstructions. We ran additional 3D classifications using 
the preliminary reconstructions from the previous step to select for particles contributing to 
homogenous classes (stable helicity and separation of β-strands in the X-Y plane). Typically, 
we performed Class3D jobs with K=3 and manual control of the tau_fudge factor and 
healpix to reach a resolution of ~5–6 Å to select for particles that contributed to the highest 
resolution class for each structure. For the SegB and SegA-slow reconstructions, we 
performed high-resolution gold-standard refinement as described51. For SegA-sym and 
SegA-asym, perhaps due to low particle numbers, Refine3D seemed unable to adequately 
regulate working resolution to refine with high enough resolution factors to allow SegA-sym 
and SegA-asym reconstructions to refine past 4.8 Å, and gold-standard refinement did not 
result in near-atomic resolution maps. Therefore, we employed a “sub-optimal” manual 
refinement protocol using all particles against a single reference map as described2,49. Final 
overall resolution estimates were calculated from the corrected Fourier shell correlations of 
two half maps, using high-resolution phase randomization as implemented in RELION 
PostProcess to account for effects of a soft-edged solvent mask and to monitor possible 
overfitting for the SegA-sym and SegA-asym manual refinements52. For the SegB and 
SegA-slow gold-standard refinements, we report the 0.143 FSC resolution cutoff; however, 
for the SegA-sym and SegA-asym “sub-optimal” refinements we report the 0.5 FSC 
resolution cutoff (the particles contributing to the final map were split a posteriori into even 
and odd micrographs to prevent particles from the same fibril contributing to different 
reconstructions and two half-maps were reconstructed using the fully refined center and 
orientation parameters)52. In all cases except the SegA-slow, the default value of 30% was 
used for the helical_z_percentage during 3D classification and refinement. Since the 
crossover distance of the SegA-slow varied from 1200–2000 Å, we used 10% for the 
helical_z_percentage to minimize the blurring due to the variable twist as described19. 
Reconstructions were compared against the reference-free 2D class averages to confirm their 
validity. In addition, de novo model-building also confirms the validity of the 3D 
reconstructions.
Specific determination of helical symmetry for all structures was performed as follows. For 
SegA-sym, SegA-asym, and SegB A315E, we estimated the crossover distances using a 
combination of manual inspection of the micrographs and inspection of 2D class averages 
using larger particle box sizes to capture the entire crossover distance (box sizes from 432 to 
1024 pixels were tested). In the case of the SegA-sym and the SegB A315E, the mirror 
symmetry axis parallel to the helical axis in the 2D class averages indicated either a two-start 
helix symmetry with a rise of 2.4 Å or a Cn rotational symmetry. Computed diffraction 
patterns from the 2D class averages indicated there was no meridional reflection at 4.8 Å, 
indicating the lack of Cn rotational symmetry. Therefore, for both of these species, a helical 
rise of 2.4 Å was assumed and the helical twist was calculated from the previously estimated 
crossover distance. Convergence to a stable helicity and high-resolution refinement to near-
atomic resolution allowing de novo model building confirmed the helical symmetry. For 
SegA-slow, the entire crossover distance could not be captured by the 1024 box size, so the 
crossover distance was estimated from a combination of manual inspection of micrographs 
Cao et al. Page 13
Nat Struct Mol Biol. Author manuscript; available in PMC 2020 February 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
and a “stitched” together fibril using the 2D classes from the 288 box size (Supplementary 
Figure 3f). Class averages, as well as the computed diffraction pattern from the “stitched” 
fibril, confirm the presence of a meridional reflection at 4.8 Å, indicating Cn rotational 
symmetry. Therefore, we assumed a helical rise of 4.8 Å and we calculated the helical twist 
from the previously estimated crossover distance. High-resolution refinement to near-atomic 
resolution allowed de novo model building, confirming the helical symmetry. In addition, 
reconstructions with a helical rise of 2.4 Å did not show clear side chain density, and 
projections of the reconstruction did not match the 2D class averages (Supplementary Figure 
3e). For SegA-asym, the crossover distance was estimated from a combination of inspection 
of the micrographs, and 2D class averages with larger box sizes. Due to the lack of apparent 
two-fold symmetry in the 2D class averages, we assumed a helical rise of 4.8 Å and 
calculated the helical twist from the measured cross-over distances. Refinement to near-
atomic resolution demonstrate that the two SegA-asym monomers within each asymmetric 
unit are not identical, confirming the lack of two-fold symmetry.
Atomic model building
We sharpened the refined maps using phenix.auto_sharpen53 at the resolution cutoff 
indicated by half-map FSC, and subsequently built atomic models into the refined maps with 
COOT54. For the three SegA polymorphs, we built the model of SegA-slow first owing to its 
high resolution (3.3 Å). The density map of SegA-slow clearly shows a cyclic mainchain 
with the amino and carboxy termini at the center of the fibril. The initial model was built 
with both N-C orientations, and only the orientation shown in the current model fit all the 
side chain densities. The conservation of the dagger-fold in the maps of SegA-sym and 
SegA-asym, especially the signature 334WGMMGML340 motif, allowed us to rigid-body fit 
the model of SegA-slow into SegA-sym and SegA-asym maps. Following rigid-body fitting, 
we manually inspected and adjusted each residue.
After building atomic models for the main chain of SegA polymorphs, we observed extra 
density peripheral to the dagger-shaped fold around Gln331 of SegA-slow and Met323 of 
both SegA-asym and SegA-slow (Figure 1c–d). We believe this density arises from unstable 
interactions (either due to weak binding or binding of a mixture of different residues) of 
other protomers with the core protofilaments. We could not build a definitive model due to 
ambiguity of the side-chain densities; however, we built a hypothetical model into the 
density near Gln331 of SegA-slow based on the speculation that this density represents part 
of the continuous dimer interface found in SegA-sym and SegA-asym.
During model building of SegA-slow, we found that the model that fully recapitulates the 
registration of SegA-sym was not favorable due to the steric clash at L340 and unexplained 
side chain density at G338 (Supplementary Figure 6c). Therefore, we built the model with a 
registration that has a 2 residue offset compared to SegA-sym. We believe that this 
registration shift is allowed by the similarity of nearby residues (Gln331 from dagger-fold 
flanked by Ser342 and Gln344 from the short chain, compared to Gln331 flanked by Gln344 
and Gln346), and is caused by the lack of the hydrophobic anchor formed by Met336 and 
Leu340 (Supplementary Figure 6d). A similar registration shift was observed in previous 
reported crystal structures of steric-zippers and was termed registration polymorphism55. 
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The extra densities near Met323 in SegA-asym and SegA-slow could represent an additional 
dimer interface that protects Ala321, Met323 and Ala325 from the solvent, but without 
unambiguous side chain density, we could not build in any models for these densities.
The model building of SegB A315E was initiated by the inspection of the density map near 
the homo-dimer interface on the neck of the inner-chain R-shaped fold. The side chain 
density and nearby environment indicates the atomic model of this region should feature 4–5 
small side chain residues flanked by a big side chain residue at each side, and the only motif 
in the SegB A315E sequence that matches this criterion is 293RGGGAGL299, with only one 
orientation feasible considering the length of density at each side of this motif. With the 
model of 293RGGGAGL299 built, the rest of model was built by adding the residues one-by-
one. All sidechains fit the density unambiguously. The observation that Glu315 forms a salt-
bridge with Arg293 further supports this model. After we built the inner R-shape fold, we 
speculated that the outer R-shape fold was not a continuation of the same chain as the inner 
R-shape fold because there were not enough residues in the sequence to accommodate the 
outer R-shape fold. Therefore, the model of the outer R-shape fold was built de novo 
similarly to the inner-R-shape fold.
For all structures, after we built the initial model, we used in-house scripts to generate a 5-
layer model using the helical symmetry of the refined map, and used 
phenix.real_space_refine for model refinement56. After several rounds of refinement, we 
adjusted the orientation of the main chain oxygen and nitrogen to facilitate main chain 
hydrogen bond within the β-sheet, and we applied these mainchain hydrogen bond restraint 
for further real-space refinement. As the last step, the rotamer of each serine, glutamine and 
asparagine residue was manually inspected to ensure the energy favorable hydrogen binding. 
The final model was validated by MolProbity57.
The G304W model of SegB A315E shown in Supplementary Figure 9b was generated by 
manually changing Gly304 residues of 1-layer SegB A315E model (four glycine residues in 
four chains) to tryptophan in COOT, and we generated a 5-layer mutated model using the 
same script as for original SegB A315E model. We refined this 5-layer mutated model by 
phenix.real_space_refine using the same density map we used to refine the original model. 
The refined model shows no Ramachandran angles and rotamer outliers, and no significant 
clashes. The statistics of SegB A315E G304W model are shown in Supplementary Table 3 
and the coordinates are listed as Supplementary Data Set 1.
Energetic calculation
The stabilization energy is an adaptation of the solvation free energy described previously58, 
in which the energy is calculated as the sum of products of the area buried of each atom and 
its corresponding atomic solvation parameter (ASP). ASPs were taken from our previous 
work58. Area buried is calculated as the difference in solvent accessible surface area (SASA) 
of the reference state (i.e. unfolded state) and the SASA of the folded state. The reference 
state was measured absent all other atoms in the structure but the residue “i” and main chain 
atoms of residue i-1 and i+1. The SASA of the folded state was measured for each atom in 
the context of all amyloid fibril atoms. Fibril coordinates were extended by symmetry by 
three to five chains on either side of the reported molecule, to ensure the energetic 
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calculations were representative of the majority of molecules in a fibril, rather than a fibril 
end. To account for energetic stabilization of main chain hydrogen bonds, the ASP for 
backbone N/O elements was reassigned from −9 to 0 if they participated in a hydrogen bond. 
Similarly, if an asparagine or glutamine side chain participated in a polar ladder (two 
hydrogen bonds per amide), and was shielded from solvent (SASAfolded < 5 Å2), the ASPs 
of the side chain N and O elements were reassigned from −9 to 0. Lastly, the ASP of 
ionizable atoms (e.g. Asp, Glu, Lys, His, Arg, N-terminal amine, or C-terminal carboxylate) 
were assigned the charged value (−37/−38) unless the atoms participated in a buried ion pair, 
defined as a pair of complementary ionizable atoms within 4.2 Å distance of each other, 
each with SASAfolded < 40 Å2). In that case, the ASP of the ion pair was reassigned to −9. In 
the energy diagrams, a single color is assigned to each residue, rather than each atom. The 
color corresponds to the sum of solvation free energy values of each of the atoms in the 
residue. The energy reported for FUS in Table 2 is the average over 20 NMR models. The 
standard deviation is 1.8 kcal/mol.
Thermo-stability assays of TDP-43 and FUS fibrils
To validate the energetic calculations and test the stability of TDP-43 segment fibrils 
experimentally, pre-formed TDP-43 segment fibrils were heated at 75 °C for 30 min in a 
PCR machine, and the existence of the fibrils were checked by negative stain EM. All fibrils 
were heated in 20 mM Tris pH 7.4, 150 mM NaCl, 10 μM DTT at 50 μM monomer-
equivalent concentration.
FUS protein was purified and FUS fibrils was formed the same way as previously reported 
[ref]. FUS protein was expressed using pHis-parallel-mCherry-1FUS214 plasmid that 
contain the low complexity domain of FUS (1–214) conjugated to mCherry. Purification was 
done by Ni column and size exclusion column. The hydrogel of FUS was formed by 
incubating purified mCherry-FUS at 4 °C for 2 weeks at a concentration of 1 M. After 
hydrogel formation, a scrape of hydrogel was mixed with 20 mM Tris pH 7.4, 150 mM 
NaCl, 10 μM DTT to approximately 20x of its original volume (~50 μM monomer 
concentration). The mixture was allocated to three PCR tubes, one without heat and two 
heated at 60 °C and 75 °C for 30 min, respectively. All three samples were checked by 
negative stain EM for fibrils. The sample without heat contains abundant fibrils on the EM 
grid and the sample with heat contains no visible fibrils anywhere on the EM grid.
ThT assays
Protein was diluted into 12 μM in 20 mM Tris-HCl, pH 7.4, 500 mM NaCl, 10 μM DTT, 30 
μM ThT, and filtered using 0.1 μm Ultrafree-MC-VV centrifugal filters (Millipore). Filtered 
solution was mixed with or without 100:1 (weight basis) ULP1, with or without 5% (molar 
ratio, monomer equivalent) pre-formed fibril seeds (or 1% v/v for brain extract seeds), and 
was pipetted into a polybase black 384-well plate with optical bottom (Thermo Scientific) 
and incubated at 37 °C without shaking. ThT fluorescence was measured with excitation and 
emission wavelength of 440 and 480 nm, respectively, using FLUOstar Omega plate reader 
(BMG LABTECH). The aggregation curves were averaged from four independent measured 
replicates and error bars show s.d. of replicate measurements. Fibril seeds were sonicated (1s 
on/1s off cycle, 3 min) before use to increase the seeding ability.
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The brain extracted materials were a generous gift from Prof. Virginia Lee’s lab. Brain 
extract #1 was from a patient diagnosed as FTLD-TDP, whereas brain extract #2 was from a 
patient diagnosed as FTLD-TDP-GRN. Both brain extracts were extracted from the frontal 
cortex, and estimated TDP-43 concentration were ~500 ng/ml (measured by ELISA assays) 
and estimated total protein concentration were 2.5 mg/ml for brain extract #1 and 4 mg/ml 
for brain extract #2 (measured by BCA assays).
The samples mixed with pre-formed fibril seeds had an additional ThT background reading 
because of the seeds. To better compare the curves of samples with and without seeding and 
estimate the ThT signal change that represented the formation of seeded fibrils, we removed 
the background by subtracting the value of the first reading from each curve. To normalize 
the different ranges of fluorescence readings observed from each experiments (probably due 
to the different fluorescence gain settings of the plate reader), we normalized the readings to 
make the minimum mean value in each panel 0%, and the maximum mean value in each 
panel 100%.
TDP-CTF aggregation assays
The aggregation assays of pathological fragments of TDP-43 (TDP-CTF) were performed 
largely the same as previous reported22. The SUMO-TDP-CTF wild type and mutants were 
diluted into 0.2 mg/ml with 20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 10 μM DTT and 
filtered by 0.1 μm Ultrafree-MC-VV centrifugal filters (Millipore). To simplify the 
experiment, we did not remove SUMO-tag by ULP1 protease because we found that wild 
type TDP-CTF aggregates after overnight incubation even with the protection of SUMO. 
Filtered samples were incubated at 4 °C overnight, and separated into supernatant and pellet 
fractions by centrifugation at 18,000 g for 3min at 4 °C. The pellet was resuspended with the 
same buffer and volume, and both supernatant and pellet were mixed with 3:1 (v/v) of 
NuPAGE LDS sample buffer (Invitrogen) and heated to 100 °C for 10 min. The samples 
before incubation were also prepared in the same way. All samples were separated by 
NuPAGE 4–12% Bis-Tris gels (Invitrogen) and stained by Coomassie blue. TDP-CTF 
A324W that had been shown to reduce TDP-CTF aggregation previously22 was also tested 
in this study as a control to make sure that we can get the similar results with or without 
ULP1 cleavage.
Further information on experimental design is available in the Nature Research Reporting 
Summary linked to this article.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
ACKNOWLEDGMENTS
We thank H. Zhou for use of Electron Imaging Center for Nanomachines (EICN) resources. We acknowledge the 
use of instruments at the EICN supported by UCLA and by instrumentation grants from NIH (1S10RR23057 and 
1U24GM116792) and NSF (DBI-1338135 and DMR-1548924). The authors acknowledge NIH AG 054022, NIH 
AG061847, and DOE DE-FC02–02ER63421 for support. D.R.B. was supported by the National Science 
Foundation Graduate Research Fellowship Program.
Cao et al. Page 17
Nat Struct Mol Biol. Author manuscript; available in PMC 2020 February 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
REFERENCES
1. Anfinsen CB Principles that govern the folding of protein chains. Science 181, 223–230 (1973). 
[PubMed: 4124164] 
2. Li B. et al. Cryo-EM of full-length α-synuclein reveals fibril polymorphs with a common structural 
kernel. Nat. Commun. 9, 3609 (2018). [PubMed: 30190461] 
3. Zhang W. et al. Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer’s 
and Pick’s disease. (2018). doi:10.1101/468892
4. Neumann M. et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic 
Lateral Sclerosis. Science 314, 130–133 (2006). [PubMed: 17023659] 
5. Hasegawa M. et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic 
lateral sclerosis. Ann. Neurol. 64, 60–70 (2008). [PubMed: 18546284] 
6. Irwin DJ et al. Frontotemporal lobar degeneration: defining phenotypic diversity through 
personalized medicine. Acta Neuropathol. (Berl.) 129, 469–491 (2015). [PubMed: 25549971] 
7. Amador‐Ortiz C. et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease. 
Ann. Neurol. 61, 435–445 (2007). [PubMed: 17469117] 
8. Nakashima-Yasuda H. et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. 
Acta Neuropathol. (Berl.) 114, 221–229 (2007). [PubMed: 17653732] 
9. Schwab C, Arai T, Hasegawa M, Yu S. & McGeer PL Colocalization of transactivation-responsive 
DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J. Neuropathol. Exp. 
Neurol. 67, 1159–1165 (2008). [PubMed: 19018245] 
10. Salajegheh M. et al. Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis. 
Muscle Nerve 40, 19–31 (2009). [PubMed: 19533646] 
11. Nelson PT et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus 
working group report. Brain J. Neurol. (2019). doi:10.1093/brain/awz099
12. Buratti E. & Baralle FE The multiple roles of TDP-43 in pre-mRNA processing and gene 
expression regulation. RNA Biol. 7, 420–429 (2010). [PubMed: 20639693] 
13. Lee EB, Lee VM-Y & Trojanowski JQ Gains or losses: molecular mechanisms of TDP43-mediated 
neurodegeneration. Nat. Rev. Neurosci. 13, 38–50 (2011). [PubMed: 22127299] 
14. Iguchi Y. et al. TDP-43 depletion induces neuronal cell damage through dysregulation of Rho 
family GTPases. J. Biol. Chem. 284, 22059–22066 (2009).
15. Kraemer BC et al. Loss of murine TDP-43 disrupts motor function and plays an essential role in 
embryogenesis. Acta Neuropathol. (Berl.) 119, 409–419 (2010). [PubMed: 20198480] 
16. Wang J. et al. Cell-autonomous requirement of TDP-43, an ALS/FTD signature protein, for 
oligodendrocyte survival and myelination. Proc. Natl. Acad. Sci. 115, E10941–E10950 (2018).
17. Tycko R. Molecular Structure of Aggregated Amyloid-β: Insights from Solid-State Nuclear 
Magnetic Resonance. Cold Spring Harb. Perspect. Med. 6, (2016).
18. Gremer L. et al. Fibril structure of amyloid-β(1–42) by cryo–electron microscopy. Science 358, 
116–119 (2017). [PubMed: 28882996] 
19. Fitzpatrick AWP et al. Cryo-EM structures of tau filaments from Alzheimer’s disease. Nature 547, 
185–190 (2017). [PubMed: 28678775] 
20. Falcon B. et al. Structures of filaments from Pick’s disease reveal a novel tau protein fold. Nature 
561, 137–140 (2018). [PubMed: 30158706] 
21. Iadanza MG et al. The structure of a β 2 -microglobulin fibril suggests a molecular basis for its 
amyloid polymorphism. Nat. Commun. 9, 4517 (2018). [PubMed: 30375379] 
22. Guenther EL et al. Atomic structures of TDP-43 LCD segments and insights into reversible or 
pathogenic aggregation. Nat. Struct. Mol. Biol. 25, 463–471 (2018). [PubMed: 29786080] 
23. Guenther EL et al. Atomic-level evidence for packing and positional amyloid polymorphism by 
segment from TDP-43 RRM2. Nat. Struct. Mol. Biol. 25, 311–319 (2018). [PubMed: 29531287] 
24. Igaz LM et al. Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological 
Features of TDP-43 Proteinopathies. J. Biol. Chem. 284, 8516–8524 (2009). [PubMed: 19164285] 
Cao et al. Page 18
Nat Struct Mol Biol. Author manuscript; available in PMC 2020 February 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
25. Pesiridis GS, Lee VM-Y & Trojanowski JQ Mutations in TDP-43 link glycine-rich domain 
functions to amyotrophic lateral sclerosis. Hum. Mol. Genet. 18, R156–162 (2009). [PubMed: 
19808791] 
26. Kato M. & McKnight SL A Solid-State Conceptualization of Information Transfer from Gene to 
Message to Protein. Annu. Rev. Biochem. 87, 351–390 (2018). [PubMed: 29195049] 
27. Hughes MP et al. Atomic structures of low-complexity protein segments reveal kinked β sheets 
that assemble networks. Science 359, 698–701 (2018). [PubMed: 29439243] 
28. Jiang L-L et al. Structural transformation of the amyloidogenic core region of TDP-43 protein 
initiates its aggregation and cytoplasmic inclusion. J. Biol. Chem. 288, 19614–19624 (2013). 
[PubMed: 23689371] 
29. Guo W. et al. An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril 
formation and neurotoxicity. Nat. Struct. Mol. Biol. 18, 822–830 (2011). [PubMed: 21666678] 
30. Lim L, Wei Y, Lu Y. & Song J. ALS-Causing Mutations Significantly Perturb the Self-Assembly 
and Interaction with Nucleic Acid of the Intrinsically Disordered Prion-Like Domain of TDP-43. 
PLoS Biol. 14, e1002338 (2016).
31. Wegorzewska I, Bell S, Cairns NJ, Miller TM & Baloh RH TDP-43 mutant transgenic mice 
develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. 106, 
18809–18814 (2009).
32. Xu M. et al. Characterization of β-domains in C-terminal fragments of TDP-43 by scanning 
tunneling microscopy. J. Struct. Biol. 181, 11–16 (2013). [PubMed: 23138004] 
33. Shimonaka S, Nonaka T, Suzuki G, Hisanaga S. & Hasegawa M. Templated Aggregation of TAR 
DNA-binding Protein of 43 kDa (TDP-43) by Seeding with TDP-43 Peptide Fibrils. J. Biol. Chem. 
291, 8896–8907 (2016). [PubMed: 26887947] 
34. Murray DT et al. Structure of FUS Protein Fibrils and Its Relevance to Self-Assembly and Phase 
Separation of Low-Complexity Domains. Cell 171, 615–627.e16 (2017).
35. Porta S. et al. Patient-derived frontotemporal lobar degeneration brain extracts induce formation 
and spreading of TDP-43 pathology in vivo. Nat. Commun. 9, 4220 (2018). [PubMed: 30310141] 
36. Fujita Y, Ikeda M, Yanagisawa T, Senoo Y. & Okamoto K. Different clinical and neuropathologic 
phenotypes of familial ALS with A315E TARDBP mutation. Neurology 77, 1427–1431 (2011). 
[PubMed: 21956716] 
37. Laferrière F. et al. TDP-43 extracted from frontotemporal lobar degeneration subject brains 
displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. 
Nat. Neurosci. 22, 65 (2019). [PubMed: 30559480] 
38. Clavaguera F. et al. Brain homogenates from human tauopathies induce tau inclusions in mouse 
brain. Proc. Natl. Acad. Sci. 110, 9535–9540 (2013). [PubMed: 23690619] 
39. Peng C. et al. Cellular milieu imparts distinct pathological α-synuclein strains in α-
synucleinopathies. Nature 557, 558 (2018). [PubMed: 29743672] 
40. Falcon B. et al. Tau filaments from multiple cases of sporadic and inherited Alzheimer’s disease 
adopt a common fold. Acta Neuropathol. (Berl.) (2018). doi:10.1007/s00401-018-1914-z
41. Ramaswami M, Taylor JP & Parker R. Altered ribostasis: RNA-protein granules in degenerative 
disorders. Cell 154, 727–736 (2013). [PubMed: 23953108] 
42. Conicella AE, Zerze GH, Mittal J. & Fawzi NL ALS mutations disrupt phase separation mediated 
by -helical structure in the TDP-43 low complexity C-terminal domain. Structure 24, 1537–1549 
(2016). [PubMed: 27545621] 
43. Fratta P. et al. Mice with endogenous TDP-43 mutations exhibit gain of splicing function and 
characteristics of amyotrophic lateral sclerosis. EMBO J. 37, (2018).
METHODS-ONLY REFERENCES
44. Suloway C. et al. Automated molecular microscopy: the new Leginon system. J. Struct. Biol. 151, 
41–60 (2005). [PubMed: 15890530] 
45. Grant T. & Grigorieff N. Automatic estimation and correction of anisotropic magnification 
distortion in electron microscopes. J. Struct. Biol. 192, 204–208 (2015). [PubMed: 26278979] 
Cao et al. Page 19
Nat Struct Mol Biol. Author manuscript; available in PMC 2020 February 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
46. Rohou A. & Grigorieff N. CTFFIND4: Fast and accurate defocus estimation from electron 
micrographs. J. Struct. Biol. 192, 216–221 (2015). [PubMed: 26278980] 
47. Grant T. & Grigorieff N. Measuring the optimal exposure for single particle cryo-EM using a 2.6 Å 
reconstruction of rotavirus VP6. eLife 4, e06980 (2015).
48. Tang G. et al. EMAN2: an extensible image processing suite for electron microscopy. J. Struct. 
Biol. 157, 38–46 (2007). [PubMed: 16859925] 
49. Guenther EL et al. Atomic-level evidence for packing and positional amyloid polymorphism by 
segment from TDP-43 RRM2. Nat. Struct. Mol. Biol. 25, 311–319 (2018). [PubMed: 29531287] 
50. He S. & Scheres SHW Helical reconstruction in RELION. J. Struct. Biol. 198, 163–176 (2017). 
[PubMed: 28193500] 
51. Scheres SHW RELION: Implementation of a Bayesian approach to cryo-EM structure 
determination. J. Struct. Biol. 180, 519–530 (2012). [PubMed: 23000701] 
52. Chen S. et al. High-resolution noise substitution to measure overfitting and validate resolution in 
3D structure determination by single particle electron cryomicroscopy. Ultramicroscopy 135, 24–
35 (2013). [PubMed: 23872039] 
53. Terwilliger TC, Sobolev OV, Afonine PV & Adams PD Automated map sharpening by 
maximization of detail and connectivity. Acta Crystallogr. Sect. Struct. Biol. 74, 545–559 (2018).
54. Emsley P, Lohkamp B, Scott WG & Cowtan K. Features and development of Coot. Acta 
Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010). [PubMed: 20383002] 
55. Wiltzius JJW et al. Molecular mechanisms for protein-encoded inheritance. Nat. Struct. Mol. Biol. 
16, 973–978 (2009). [PubMed: 19684598] 
56. Afonine PV et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta 
Crystallogr. Sect. Struct. Biol. 74, 531–544 (2018).
57. Chen VB et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta 
Crystallogr. D Biol. Crystallogr. 66, 12–21 (2010). [PubMed: 20057044] 
58. D E, M, W. & M Y. Interpretation of protein folding and binding with atomic solvation parameters. 
Chemica Scripta (1989). Available at: https://eurekamag.com/research/032/001/032001963.php. 
(Accessed: 20th December 2018)
Cao et al. Page 20
Nat Struct Mol Biol. Author manuscript; available in PMC 2020 February 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. Cryo-EM Structure of TDP-43 polymorphic fibrils.
a, Schematic of full-length TDP-43. SegA (residues 311–360) and SegB (residues 286–331) 
identified for structural determination are shown as gray bars, respectively above and below 
the low-complexity domain (LCD). The color bars show the range of residues visualized in 
the structure of each polymorph. Panels b-e: (left) fibril reconstructions showing left-handed 
twist and pitch; (middle) density and atomic model of one cross-sectional layer of each 
fibril; (right) schematic model showing protein chain (blue) and residues (hydrophobic in 
yellow, polar in green, glycine in pink, glutamate in red, and arginine in blue).
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Figure 2. Structure of the dagger-shaped fold and the R-shaped fold.
a,Superposition of the dagger-shaped folds (residue 312–346) in three SegA polymorphic 
fibrils. The core region of the dagger-shaped folds (residue 320–334) is colored red with side 
chains shown, and the rest of the dagger-shaped fold is colored according to the key. b, 
Atomic model of SegA-sym. c, Pairwise superposition of the dagger-shaped fold of SegA-
sym vs. SegA-asym long chain. d, Continuous dimer interface of SegA-sym. e, Atomic 
model of SegB A315E. Each of the four chains is R-shaped, with a pseudo-21 axis relating 
the two pairs. The inner two chains are identical as are the two outer chains. f, Structures of 
the inner (left) and outer (middle) chains and their superposition (right). Notice the 
proximity of R293 to the pathogenic variant E315 which replaces A315 in the reference 
sequence. g, View parallel to the fibril axis showing the symmetric interface between the two 
inner chains (left) and the asymmetric interface between the inner and outer chains (right). 
h, View perpendicular to the fibril showing the inter-layer interaction of Arg293 with 
Glu315 on the inner chain (left) and outer chain (right). (Detailed alignment parameters and 
RMSD values listed in Supplementary Table 2).
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Figure 3. Calculated solvation energy maps for TDP-43 fibrils based on atomic solvation 
parameters.
Solvation energy maps of SegA-sym (left) and SegB A315E (right). Residues are colored 
from unfavorable (blue, −2.5 kcal/mol) to favorable stabilization energy (red, 2.5 kcal/mol). 
Notice that both the dagger-shaped fold (SegA-sym) and the R-shaped fold (SegB A315E) 
show stable cores.
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Figure 4. Speculative model of TDP-43 amyloid aggregation based on fibril structures reported 
here.
a, (Left) Monomeric TDP-43 can form amyloid fibrils with either dagger-shaped or R-
shaped cores (or perhaps other so far unidentified cores). The ALS hereditary A315E 
mutation accelerates the R-shaped core through electrostatic interaction of Glu315 with 
Arg293. b, Experiments seeding TDP-43 fibril formation support the model of Panel A. 
Notice that both SegA and SegB A315E fibrils seed LCD monomer (far left and middle 
left). In contrast, only SegB A315E fibrils seed LCD A315E monomer whereas SegA fibrils 
barely seed LCD A315E monomer (far right and middle right). Data are shown as mean ± 
s.d., n=4 independent experiments.
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Table 1
Cryo-EM data collection, refinement and validation statistics
SegA-sym (EMD-9339, 
PDB 6N37)
SegA-asym 
(EMD-9350, PDB 
6N3B)
SegA-slow 
(EMD-9349, PDB 
6N3A)
SegB A315E 
(EMD-0334, PDB 
6N3C)
Data collection and processing
Magnification ×130,000 ×130,000 ×130,000 ×130,000
Voltage (kV) 300 300 300 300
Electron exposure (e–/Å2) 44 44 44 44
Defocus range (μm) 1.1–3.9 1.1–4.4 1.0–9.9 0.5–4.9
Pixel size (Å) 1.064 1.064 1.064 1.06
Symmetry imposed C1 C1 C2 C1
Helical rise (Å) 2.38 4.81 4.84 2.41
Helical twist (°) 178.61 −2.27 179.34 179.36
Initial particle images (no.) 92,568 92,568 499,065 361,182
Final particle images (no.) 8,033 15,464 167,087 44,085
Map resolution (Å) 3.8 3.8 3.3 3.3
 FSC threshold 0.5 0.5 0.143 0.143
Map resolution range (Å) 200–3.8 200–3.8 200–3.3 200–3.3
Refinement
Initial model used (PDB code) De novo De novo De novo De novo
Model resolution (Å) 3.8 3.8 3.2 3.2
 FSC threshold 0.5 0.5 0.5 0.5
Model resolution range (Å) 200–3.8 200–3.8 200–3.2 200–3.2
Map sharpening B factor (Å2) −87 −93 −134 −154
Model composition
 Nonhydrogen atoms 2580 2735 4310 4260
 Protein residues 360 385 600 640
 Ligands 0 0 0 0
B factors (Å2)
 Protein 75.8 105.4 108.6 72.2
 Ligand - - - -
R.m.s. deviations
 Bond lengths (Å) 0.009 0.010 0.008 0.009
 Bond angles (°) 1.548 1.372 1.143 1.306
Validation
MolProbity score 2.28 2.47 2.25 2.35
Clashscore 12.95 22.11 17.25 18.47
Poor rotamers (%) 0 0 0 0
Ramachandran plot
 Favored (%) 85.3 86.3 91.1 88.5
 Allowed (%) 14.7 13.7 8.9 11.5
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SegA-sym (EMD-9339, 
PDB 6N37)
SegA-asym 
(EMD-9350, PDB 
6N3B)
SegA-slow 
(EMD-9349, PDB 
6N3A)
SegB A315E 
(EMD-0334, PDB 
6N3C)
 Disallowed (%) 0 0 0 0
Nat Struct Mol Biol. Author manuscript; available in PMC 2020 February 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Cao et al. Page 27
Table 2
Comparative solvation energy calculations
Fibril Structure Energy per layer (kcal/mol) Energy per residue (kcal/mol)
SegA-sym (PDB 6N37) 73 1.0
SegA-asym (PDB 6N3B) 76 0.97 (long chain, 0.92; short chain, 1.04)
SegB A315E (PDB 6N3C) 110 0.86 (inner chain, 0.94; outer chain, 0.79)
Tau PHF (PDB 5O3L) 128 0.88
Tau SF (PDB 5O3T) 144 1.0 (chain A, 0.98; chain B, 1.02)
Tau Pick’s (PDB 6GX5) 98 1.0
FUS (PDB 5W3N) 41 0.66
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